ArticleTherapeutics and clinical risk management2022

Clinical Efficacy of a Combination of Thymopentin and Antituberculosis Drugs in Treating Drug-Resistant Pulmonary Tuberculosis: Meta Analysis.

Yi-Ran Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.